vs

Side-by-side financial comparison of Crane NXT, Co. (CXT) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $476.9M, roughly 1.5× Crane NXT, Co.). Healthpeak Properties runs the higher net margin — 73.2% vs 10.0%, a 63.2% gap on every dollar of revenue. On growth, Crane NXT, Co. posted the faster year-over-year revenue change (19.5% vs 3.1%). Over the past eight quarters, Crane NXT, Co.'s revenue compounded faster (23.3% CAGR vs 8.9%).

Crane Co. is an American industrial products company based in Stamford, Connecticut. Founded by Richard Teller Crane in 1855, it became one of the leading manufacturers of bathroom fixtures in the United States, until 1990, when that division was sold off. In 1960 it began the process of becoming a holding company with a diverse portfolio. Its business segments are Aerospace & Electronics, Engineered Materials, Fluid Handling, and Controls. Industries served by these segments include chemical...

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CXT vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.5× larger
DOC
$719.4M
$476.9M
CXT
Growing faster (revenue YoY)
CXT
CXT
+16.4% gap
CXT
19.5%
3.1%
DOC
Higher net margin
DOC
DOC
63.2% more per $
DOC
73.2%
10.0%
CXT
Faster 2-yr revenue CAGR
CXT
CXT
Annualised
CXT
23.3%
8.9%
DOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CXT
CXT
DOC
DOC
Revenue
$476.9M
$719.4M
Net Profit
$47.5M
$114.0M
Gross Margin
42.4%
Operating Margin
16.7%
17.4%
Net Margin
10.0%
73.2%
Revenue YoY
19.5%
3.1%
Net Profit YoY
2406.4%
EPS (diluted)
$0.82
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXT
CXT
DOC
DOC
Q4 25
$476.9M
$719.4M
Q3 25
$445.1M
$705.9M
Q2 25
$404.4M
$694.3M
Q1 25
$330.3M
$702.9M
Q4 24
$399.1M
$698.0M
Q3 24
$403.5M
$700.4M
Q2 24
$370.6M
$695.5M
Q1 24
$313.6M
$606.6M
Net Profit
CXT
CXT
DOC
DOC
Q4 25
$47.5M
$114.0M
Q3 25
$50.5M
$-117.1M
Q2 25
$24.9M
$31.7M
Q1 25
$21.7M
$42.8M
Q4 24
$4.5M
Q3 24
$47.1M
$85.9M
Q2 24
$41.6M
$146.0M
Q1 24
$37.8M
$6.7M
Gross Margin
CXT
CXT
DOC
DOC
Q4 25
42.4%
Q3 25
43.3%
58.6%
Q2 25
41.7%
60.2%
Q1 25
42.4%
61.1%
Q4 24
45.2%
60.3%
Q3 24
42.5%
60.0%
Q2 24
43.4%
60.6%
Q1 24
48.6%
59.8%
Operating Margin
CXT
CXT
DOC
DOC
Q4 25
16.7%
17.4%
Q3 25
18.4%
9.2%
Q2 25
11.8%
5.7%
Q1 25
11.3%
7.7%
Q4 24
17.7%
-2.2%
Q3 24
18.6%
14.1%
Q2 24
18.2%
22.3%
Q1 24
17.7%
3.7%
Net Margin
CXT
CXT
DOC
DOC
Q4 25
10.0%
73.2%
Q3 25
11.3%
-16.6%
Q2 25
6.2%
4.6%
Q1 25
6.6%
6.1%
Q4 24
0.7%
Q3 24
11.7%
12.3%
Q2 24
11.2%
21.0%
Q1 24
12.1%
1.1%
EPS (diluted)
CXT
CXT
DOC
DOC
Q4 25
$0.82
$0.16
Q3 25
$0.87
$-0.17
Q2 25
$0.43
$0.05
Q1 25
$0.38
$0.06
Q4 24
$1.00
$0.02
Q3 24
$0.81
$0.12
Q2 24
$0.72
$0.21
Q1 24
$0.66
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXT
CXT
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$233.8M
$467.5M
Total DebtLower is stronger
$1.0B
$9.8B
Stockholders' EquityBook value
$1.3B
$7.5B
Total Assets
$3.1B
$20.3B
Debt / EquityLower = less leverage
0.80×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXT
CXT
DOC
DOC
Q4 25
$233.8M
$467.5M
Q3 25
$182.4M
$91.0M
Q2 25
$152.5M
$89.4M
Q1 25
$173.8M
$70.6M
Q4 24
$165.8M
$119.8M
Q3 24
$165.1M
$180.4M
Q2 24
$175.5M
$106.9M
Q1 24
$220.6M
$101.8M
Total Debt
CXT
CXT
DOC
DOC
Q4 25
$1.0B
$9.8B
Q3 25
$834.3M
$9.1B
Q2 25
$861.8M
$9.0B
Q1 25
$541.1M
$8.9B
Q4 24
$540.6M
$8.7B
Q3 24
$638.2M
$8.6B
Q2 24
$638.9M
$8.6B
Q1 24
$639.6M
$8.8B
Stockholders' Equity
CXT
CXT
DOC
DOC
Q4 25
$1.3B
$7.5B
Q3 25
$1.2B
$7.6B
Q2 25
$1.2B
$7.9B
Q1 25
$1.1B
$8.2B
Q4 24
$1.1B
$8.4B
Q3 24
$1.1B
$8.6B
Q2 24
$989.8M
$8.8B
Q1 24
$964.1M
$8.9B
Total Assets
CXT
CXT
DOC
DOC
Q4 25
$3.1B
$20.3B
Q3 25
$2.9B
$19.6B
Q2 25
$2.9B
$19.8B
Q1 25
$2.4B
$19.8B
Q4 24
$2.4B
$19.9B
Q3 24
$2.4B
$20.0B
Q2 24
$2.4B
$20.2B
Q1 24
$2.1B
$20.5B
Debt / Equity
CXT
CXT
DOC
DOC
Q4 25
0.80×
1.31×
Q3 25
0.69×
1.20×
Q2 25
0.73×
1.14×
Q1 25
0.49×
1.08×
Q4 24
0.51×
1.04×
Q3 24
0.60×
1.00×
Q2 24
0.65×
0.98×
Q1 24
0.66×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXT
CXT
DOC
DOC
Operating Cash FlowLast quarter
$105.8M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
2.23×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXT
CXT
DOC
DOC
Q4 25
$105.8M
$1.3B
Q3 25
$92.0M
$315.0M
Q2 25
$62.8M
$363.5M
Q1 25
$-19.1M
$279.4M
Q4 24
$81.1M
$1.1B
Q3 24
$66.7M
$318.2M
Q2 24
$56.8M
$316.2M
Q1 24
$9.5M
$152.6M
Free Cash Flow
CXT
CXT
DOC
DOC
Q4 25
$357.0M
Q3 25
$78.7M
Q2 25
$55.8M
Q1 25
$-32.2M
Q4 24
$333.7M
Q3 24
$53.5M
Q2 24
$47.9M
Q1 24
$-3.0M
FCF Margin
CXT
CXT
DOC
DOC
Q4 25
49.6%
Q3 25
17.7%
Q2 25
13.8%
Q1 25
-9.7%
Q4 24
47.8%
Q3 24
13.3%
Q2 24
12.9%
Q1 24
-1.0%
Capex Intensity
CXT
CXT
DOC
DOC
Q4 25
124.4%
Q3 25
3.0%
Q2 25
1.7%
Q1 25
4.0%
Q4 24
105.6%
Q3 24
3.3%
Q2 24
2.4%
Q1 24
4.0%
Cash Conversion
CXT
CXT
DOC
DOC
Q4 25
2.23×
10.99×
Q3 25
1.82×
Q2 25
2.52×
11.48×
Q1 25
-0.88×
6.52×
Q4 24
235.43×
Q3 24
1.42×
3.71×
Q2 24
1.37×
2.17×
Q1 24
0.25×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXT
CXT

Other$260.9M55%
Products$181.1M38%
Services$34.9M7%

DOC
DOC

Segment breakdown not available.

Related Comparisons